Ben Palmer

Haemophilia Foundation Australia — Australia

Medicine · Health Sciences

19h-index1.4kcitations30works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(15), Platelet Disorders and Treatments(7), Systemic Lupus Erythematosus Research(4), Blood Coagulation and Thrombosis Mechanisms(4), Coagulation, Bradykinin, Polyphosphates, and Angioedema(4)

Publications30 total

Longer-term Survival of UK People with Bleeding Disorders Infected by Human Immunodeficiency Virus and/or Hepatitis C Virus Through Contaminated Blood Transfusions
Epidemiology·2025Open Access
Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors’ Organisation
Research and Practice in Thrombosis and Haemostasis·2025· 1 citedOpen Access
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO)
Haemophilia·2023· 22 citedOpen Access
Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia Database and Haemtrack patient reported data: an observational study
BMJ Open·2022· 25 citedOpen Access
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update
Haemophilia·2021· 29 citedOpen Access
Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors’ Organisation centers for patients with unclassified bleeding disorders
Journal of Thrombosis and Haemostasis·2021· 14 citedOpen Access
Prevalence of Haemarthrosis and Clinical Impact on The Musculoskeletal System in People With Haemophilia in The United Kingdom; Evaluation of UK National Haemophilia Database and Haemtrack Patient Reported Data.
Research Square (Research Square)·2020· 1 citedOpen Access
P107 Prevalence of haemarthrosis and clinical impact on the musculoskeletal system in people with haemophilia in the United Kingdom: evaluation of UKHCDO and haemtrack patient reported data
Lara D. Veeken·2020Open Access
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies
Haemophilia·2019· 28 cited
The immunogenicity of ReFacto <scp>AF</scp> (moroctocog alfa <scp>AF</scp>‐<scp>CC</scp>) in previously untreated patients with haemophilia A in the United Kingdom
Haemophilia·2018· 12 cited
Intracranial haemorrhage in children with inherited bleeding disorders in the <scp>UK</scp> 2003‐2015: A national cohort study
Haemophilia·2018· 55 cited
Treatment burden, haemostatic strategies and real world inhibitor screening practice in non‐severe haemophilia A
British Journal of Haematology·2017· 24 citedOpen Access
Antidepressant drugs and generic counselling for treatment of major depression in primary care
2016
Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A
Thrombosis and Haemostasis·2015· 19 cited
A national survey of immunosuppression strategies for acquired haemophilia A
Haemophilia·2014· 3 cited
The incidence of factor <scp>VIII</scp> inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor <scp>VIII</scp>: a prospective cohort comparison
Haemophilia·2014· 39 cited
Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom
Blood·2011· 170 cited
The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products
Haemophilia·2011· 34 cited
Method of Suicide in the Mentally Ill: A National Clinical Survey
Suicide and Life-Threatening Behavior·2010· 18 cited
Self-harm in England: a tale of three cities
Social Psychiatry and Psychiatric Epidemiology·2007· 398 cited
page 1 of 2Next →

Frequent Co-authors

Peter W. Collins(9), C. R. M. Hay(8), Elizabeth Chalmers(7), Daniel P. Hart(7), Michael Richards(6), Savita Rangarajan(5), Kate Talks(5), David Stephensen(5), Ri Liesner(4), Kenneth Muir(4), Mary Mathias(4), Hua Xiang(4), Carolyn Hardy(3), Jayanthi Alamelu(3), Conor Duggan(3), Richard A. Wilkins(3), Heidi J. Siddle(3), M.J. Scott(3), Graham J. Chapman(3), Paul Batty(3)